以岭药业：关于收到化学原料药上市申请批准通知书的公告

Core Points - Yiling Pharmaceutical announced the approval of its subsidiary Wanyang Hengshui Pharmaceutical's application for the chemical raw material "Mebendazole" by the National Medical Products Administration [1] Group 1 - The approval notification was received on November 12, indicating a significant regulatory milestone for the company [1] - The application for "Mebendazole" was submitted by Hengshui Wanyang, highlighting the company's ongoing efforts in expanding its product portfolio [1]